Literature DB >> 15838431

Preferential location of acute pulmonary thromboembolism induced consolidative opacities: assessment with respiratory gated perfusion SPECT-CT fusion images.

Mohammed Zaki1, Kazuyoshi Suga, Yasuhiko Kawakami, Tomio Yamashita, Kensaku Shimizu, Aska Seto, Naofumi Matsunaga.   

Abstract

PURPOSE: Preferential location of acute pulmonary thromboembolism (PTE) induced consolidative opacities (infarction/atelectasis) was determined on respiratory gated perfusion SPECT-CT fusion images.
METHOD: Gated end-inspiratory perfusion SPECT images were obtained in 21 patients with acute PTE and 17 patients with inflammatory diseases, using a triple-headed SPECT system and a respiratory tracking device. Anatomical relationships of consolidative opacities and perfusion defects were assessed on gated SPECT-rest inspiratory CT fusion images. The size and radioactivity of perfusion defects with acute PTE consolidative opacities were compared with those of defects without these opacities. The contribution of fusion images for differential diagnosis of acute PTE induced and inflammatory disease induced lesions was evaluated by receiver operating characteristic (ROC) curve analysis.
RESULTS: Of the total 56 acute PTE induced consolidative opacities, 42 (75%) were located at the peripheral interface between the severely decreased and adjacent relatively preserved perfusion areas within wedge shaped perfusion defects on fusion images. These defects with consolidative opacities were significantly larger and had taken up less radioactivity compared with those in the 86 defects without these lesions (P<0.0001). In contrast, of the 29 inflammatory disease induced opacities, 14 (48.2%) had the matched defects and 13 (44.8%) were located at the proximal portion of defects. These preferential locations of acute PTE induced and inflammation induced lesions were significantly different (P<0.01). In ROC curves, the combined reading of fusion images showed a significantly higher differential diagnostic accuracy compared with the reading of CT and SPECT images alone (P<0.01).
CONCLUSIONS: Acute PTE induced consolidative opacities preferentially occur at the peripheral lung interface between severely decreased and adjacent relatively preserved perfusion areas within relatively large and severely decreased perfusion defects. The fusion images, which provide an accurate assessment of the morphological-perfusion defect relationship could, potentially, provide a differential diagnosis between acute PTE induced and inflammatory disease induced lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838431     DOI: 10.1097/00006231-200505000-00012

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

Review 1.  A review on the clinical uses of SPECT/CT.

Authors:  Giuliano Mariani; Laura Bruselli; Torsten Kuwert; Edmund E Kim; Albert Flotats; Ora Israel; Maurizio Dondi; Naoyuki Watanabe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-25       Impact factor: 9.236

2.  Fusion imaging of computed tomographic pulmonary angiography and SPECT ventilation/perfusion scintigraphy: initial experience and potential benefit.

Authors:  Benjamin Harris; Dale Bailey; Paul Roach; Elizabeth Bailey; Gregory King
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-08       Impact factor: 9.236

3.  Assessment of Inter-modality Spatial Alignment Accuracy in Hybrid Single Photon Emission Computed Tomography in Patients with Hand and Wrist Pain.

Authors:  Cheng Xie; Gopinath Gnanasegaran; Hosahalli Mohan; Lefteris Livieratos
Journal:  World J Nucl Med       Date:  2013-09

4.  Prediction of pulmonary function after major lung resection using lung perfusion scintigraphy with single-photon emission computed tomography/computed tomography.

Authors:  Hiroshi Kawai; Toru Kawakami; Masakazu Tsujimoto; Ayami Fukushima; Satomi Isogai; Hisato Ishizawa; Hiromitsu Nagano; Takahiro Negi; Daisuke Tochii; Sachiko Tochii; Takashi Suda; Hiroshi Toyama; Yasushi Hoshikawa
Journal:  Fujita Med J       Date:  2020-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.